Skyline Vet Pharma (SVP), a specialty veterinary pharmaceutical company, is using proven delivery technologies to reformulate drugs and nutraceuticals with established animal health markets.
As a new animal health product development company employing novel delivery technologies, SVP is distinguished from its contemporaries by repositioning drugs already used in human and animal health, so avoiding drug discovery.
SVP is developing new products to address major issues in companion animal medicine today; please see the “Issues in companion animal medicine” pull down menu for further details.
Over the next year, SVP will fill senior positions in regulatory affairs, manufacturing/formulation, and clinical development. We would like to hear from candidates with five or more years of experience in those animal-health-industry functional areas and would like to work in an exciting, fast-moving startup environment.
SVP will also partner with established companies to apply novel delivery technologies to its partners’ actives in selected high-value animal markets; inquiries are welcome.